We are live on ! Find out more
LABU icon

Direxion Daily S&P Biotech Bull 3X ETF

49 hedge funds and large institutions have $50.9M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more call options, than puts

Call options by funds: $45.3M | Put options by funds: $17.9M

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

17% more capital invested

Capital invested by funds: $43.4M → $50.9M (+$7.44M)

4% more funds holding

Funds holding: 4749 (+2)

0.07% more ownership

Funds ownership: 0.16%0.23% (+0.07%)

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
12
Reduced
8
Closed
15
Calls
$45.3M
Puts
$17.9M
Net Calls
+$27.4M
Net Calls Change
+$6.86M

LABU Hedge Fund Activity: Q4 2022 in Review

49 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2022, worth a combined $50.9M — up 17% from $43.4M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new LABU positions and 15 closed out — a net gain of 3 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $11M. The largest seller was Simplex Trading, cutting an estimated $7.38M.

  • 49 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2022, up from 47 in Q3 2022.
  • Funds reported $50.9M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2022, up 17% quarter-over-quarter.
  • 18 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2022 and 15 closed out, a net change of +3 holders.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2022 was Citadel Advisors, an estimated $11M added.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2022 was Simplex Trading, an estimated $7.38M sold.

Based on aggregated 13F filings for Q4 2022.